Literature DB >> 31103262

Circ_ORC2 enhances the regulatory effect of miR-19a on its target gene PTEN to affect osteosarcoma cell growth.

Xiang Li1, Xiao-Hai Sun1, Hong-Ye Xu1, Han-Song Pan1, Yong Liu2, Long He3.   

Abstract

Osteosarcoma is a highly malignant and aggressive bone tumor. Its occurrence and development involve many factors and multiple signaling pathways. Some studies have shown that circular RNAs (circRNAs) play important roles in the development of various tumors. This research showed that circ_ORC2 was generally up-regulated in various osteosarcoma cell lines, and mainly distributed in the cytoplasm. Circ_ORC2 had the binding site of miR-19a, and its expression was positively correlated with miR-19a expression. RIP experiments showed that circ_ORC2 could bind to Ago2 protein. RNA pull-down using biotinylated circ_ORC2 or miR-19a showed that circ_ORC2 could directly interact with miR-19a, and dual luciferase reporter gene assay also confirmed that miR-19a could bind to circ_ORC2. After circ_ORC2 knockdown, miR-19a expression was down-regulated, but the downstream target gene PTEN expression was up-regulated, and the phosphorylation level of Akt was reduced, which indicated that circ_ORC2 enhanced the inhibition of miR-19a on PTEN expression by combining miR-19a. Further functional experiments showed that after circ_ORC2 knockdown, cell proliferation and invasion decreased, while the apoptosis level increased. When co-transfected with circ_ORC2 siRNA and miR-19a mimics or PTEN siRNA, the above cell biological behaviors did not change significantly. Therefore, circ_ORC2 binds with miR-19a and enhances its expression, thereby inhibiting downstream PTEN expression and activating Akt pathway to promote osteosarcoma cell growth and invasion. These findings enrich the circRNA molecular regulation mechanism, and provide more reference ideas for the research and application of circRNAs in tumors and other diseases.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Osteosarcoma; PTEN; circRNA; miR-19a

Year:  2019        PMID: 31103262     DOI: 10.1016/j.bbrc.2019.04.188

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Role of miRNA-19a in Cancer Diagnosis and Poor Prognosis.

Authors:  Alessio Ardizzone; Giovanna Calabrese; Michela Campolo; Alessia Filippone; Dario Giuffrida; Francesca Esposito; Cristina Colarossi; Salvatore Cuzzocrea; Emanuela Esposito; Irene Paterniti
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

2.  Down-regulation of circular RNA hsa_circ_0007534 suppresses cell growth by regulating miR-219a-5p/SOX5 axis in osteosarcoma.

Authors:  Peng Zhang; Jun Li
Journal:  J Bone Oncol       Date:  2021-01-18       Impact factor: 4.072

3.  Depletion of hsa_circ_0000144 Suppresses Oxaliplatin Resistance of Gastric Cancer Cells by Regulating miR-502-5p/ADAM9 Axis.

Authors:  Haifeng Gao; Jiajia Xu; Fen Qiao; Liangjun Xue
Journal:  Onco Targets Ther       Date:  2021-04-20       Impact factor: 4.147

4.  Long non-coding RNA DUXAP10 exerts oncogenic properties in osteosarcoma by recruiting HuR to enhance SOX18 mRNA stability.

Authors:  Guantong Wang; Qian Zhang; Qinjue Wang; Jing Wang; Lulu Chen; Qiang Sun; Dengshun Miao
Journal:  Hum Cell       Date:  2022-09-02       Impact factor: 4.374

5.  Long Non-Coding RNA 691 Regulated PTEN/PI3K/AKT Signaling Pathway in Osteosarcoma Through miRNA-9-5p.

Authors:  Pengju Yao; Yangming Ni; Changlu Liu
Journal:  Onco Targets Ther       Date:  2020-05-22       Impact factor: 4.147

6.  Circular RNA_CNST Promotes the Tumorigenesis of Osteosarcoma Cells by Sponging miR-421.

Authors:  Ji-Hai Wang; Xue-Jian Wu; Yong-Zhuang Duan; Feng Li
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

7.  CircORC2 is involved in the pathogenesis of slow transit constipation via modulating the signalling of miR-19a and neurotensin/motilin.

Authors:  Yuan-Yuan Wang; Rui-Yun Lu; Ji Shi; Shuai Zhao; Xia Jiang; Xiaosong Gu
Journal:  J Cell Mol Med       Date:  2021-02-24       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.